Partial epilepsies are the most common form of epilepsy in adult individuals. Antiepileptic drugs (AEDs) continue as the main form of treatment for patients with epilepsy. Regardless of the importance of the medication a high number of patients are under inappropriate or not receiving AEDs. There are several medications available for the treatment of epilepsy. The choice of a particular medication or association among AEDs may be individualized as much as possible. In this article some aspects such as classification, onset of the seizures, age, sex, associated medical conditions, cost and posology of AEDs and medical drug history are reviewed. Details of the available AEDs are also discussed. These points may help to create a profile helping the decision for the appropriate AED. Some practical issues like adverse reaction management, monotherapy and politherapy are also discussed.14SUPPL. 22531Guerreiro, C.A.M., Palmini, A., Tratamento medicamentoso das epilepsias (2002) Epilepsia, pp. 319-337. , Guerreiro CAM, Guerreiro MM, Cendes F, Lopes-Cendes I, eds. São Paulo: Lemos EditorialLi, L.M., Fernandes, P.T., Noronha, A.L., Demonstration Project on Epilepsy in Brazil: Situation assessment (2007) Arq Neuropsiquiatr, 65 (SUPPL. 1), pp. 5-13Proposal for revised classification of epilepsies and epileptic syndromes (1989) Epilepsia, 30, pp. 389-399. , Commission on Classification and Terminology of the International League Against EpilepsyThomas, P., Valton, L., Genton, P., Absence and myoclonic status epilepticus precipitated by antiepileptic drugs in idiopathic generalized epilepsy (2006) Brain, 129, pp. 1281-1292Semah, F., Picot, M.-C., Adam, C., Broglin, D., Arzimanoglou, A., Bazin, B., Cavalcanti, D., Baulac, M., Is the underlying cause of epilepsy a major prognostic factor for recurrence? (1998) Neurology, 51 (5), pp. 1256-1262Betting, L.E., Cendes, F., Crise única (2008) Tratamento Das Doenças Neurológicas, pp. 502-506. , Melo-Souza SE, ed. Rio de Janeiro: Guanabara-KooganHauser, W.A., Rich, S.S., Lee, J.R.J., Annegers, J.F., Anderson, V.E., Risk of recurrence after two unprovoked seizures (1998) N Engl J Med, 338, pp. 429-434Kwan, P., Brodie, M.J., Early identification of refractory epilepsy (2000) N Engl J Med, 342, pp. 314-319Betting, L.E., Kobayashi, E., Montenegro, M.A., Min, L.L., Cendes, F., Guerreiro, M.M., Guerreiro, C.A.M., Treatment of epilepsy: Consensus of the Brazilian specialists (2003) Arquivos de Neuro-Psiquiatria, 61 (4), pp. 1045-1070French, J.A., Kanner, A.M., Bautista, J., Abou-Khalil, B., Browne, T., Harden, C.L., Theodore, W.H., Glauser, T.A., Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy. Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society (2004) Neurology, 62 (8), pp. 1252-1260Zaccara, G., Franciotta, D., Perucca, E., Idiosyncratic adverse reactions to antiepileptic drugs (2007) Epilepsia, 48 (7), pp. 1223-1244. , DOI 10.1111/j.1528-1167.2007.01041.xBerg, A.T., Shinnar, S., Relapse following discontinuation of antiepileptic drugs: A meta-analysis (1994) Neurology, 44 (4), pp. 601-608Beghi, E., Di Mascio, R., Tognoni, G., Drug treatment of epilepsy. Outlines, criticism and perspectives (1986) Drugs, 31 (3), pp. 249-265Mattson, R.H., Cramer, J.A., Collins, J.F., Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures (1985) N Engl J Med, 313, pp. 145-151Rowan, A.J., Reflections on the treatment of seizures in the elderly population (1998) Neurology, 51, pp. S28-33Ensrud, K.E., Walczak, T.S., Blackwell, T., Ensrud, E.R., Bowman, P.J., Stone, K.L., Antiepileptic drug use increases rates of bone loss in older women: A prospective study (2004) Neurology, 62 (11), pp. 2051-2057Valimaki, M.J., Tiihonen, M., Laitinen, K., Tahtela, R., Karkkainen, M., Lamberg-Allardt, C., Makela, P., Tunninen, R., Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs (1994) Journal of Bone and Mineral Research, 9 (5), pp. 631-637Farhat, G., Yamout, B., Mikati, M.A., Demirjian, S., Sawaya, R., El-Hajj Fuleihan, G., Effect of antiepileptic drugs on bone density in ambulatory patients (2002) Neurology, 58 (9), pp. 1348-1353Sato, Y., Kondo, I., Ishida, S., Motooka, H., Takayama, K., Tomita, Y., Maeda, H., Satoh, K., Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy (2001) Neurology, 57 (3), pp. 445-449Johannessen Landmark, C., Antiepileptic drugs in non-epilepsy disorders: Relations between mechanisms of action and clinical efficacy (2008) CNS Drugs, 22 (1), pp. 27-47Vanotti, A., Osio, M., Mailland, E., Overview on pathophysiology and newer approaches to treatment of peripheral neuropathies (2007) CNS Drugs, 21 (SUPPL. 1), pp. 3-12Perucca, E., Dulac, O., Shorvon, S., Tomson, T., Harnessing the clinical potential of antiepileptic drug therapy: Dosage optimisation (2001) CNS Drugs, 15 (8), pp. 609-621Ruble, J., Matsuo, H., Anticonvulsant-induced cutaneous reactions. Incidence, mechanisms and management (1999) CNS Drugs, 12, pp. 215-236Glauser, T., Ben-Menachem, E., Bourgeois, B., Cnaan, A., Chadwick, D., Guerreiro, C., Kalviainen, R., Tomson, T., ILAE treatment guidelines: Evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes (2006) Epilepsia, 47 (7), pp. 1094-1120. , DOI 10.1111/j.1528-1167.2006.00585.xDichter, M.A., Old and new mechanisms of antiepileptic drug actions (1993) Epilepsy Res, 10 (SUPPL.), pp. 9-17Brodie, M.J., Dichter, M.A., Antiepileptic drugs (1996) N Engl J Med, 334, pp. 168-175Twyman, R.E., Rogers, C.J., Macdonald, R.L., Differential regulation of γ-aminobutyric acid receptor channels by diazepam and phenobarbital (1989) Annals of Neurology, 25 (3), pp. 213-220. , DOI 10.1002/ana.410250302Oxcarbazepine (1989) Lancet, 2, pp. 196-198Dichter, M.A., Brodie, M.J., New antiepileptic drugs (1996) N Engl J Med, 334, pp. 1583-1590Marson, A.G., Al-Kharusi, A.M., Alwaidh, M., Appleton, R., Baker, G.A., Chadwick, D.W., Cramp, C., Williamson, P.R., The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: An unblinded randomised controlled trial (2007) Lancet, 369 (9566), pp. 1000-1015. , DOI 10.1016/S0140-6736(07)60460-7, PII S0140673607604607Panayatopoulos, C.P., Evidence-based Epileptology, Randomized Controlled Trials, and SANAD: A Critical Clinical View (2007) Epilepsia, 48, pp. 1268-1274Cheung, H., Kamp, D., Harris, E., An in vitro investigation of the action of lamotrigine on neuronal voltage-activated sodium channels (1992) Epilepsy Res, 13, pp. 107-112Montenegro, M.A., Ferreira, C.M., Cendes, F., Li, L.M., Guerreiro, C.A.M., Clobazam as add-on therapy for temporal lobe epilepsy and hippocampal sclerosis (2005) Canadian Journal of Neurological Sciences, 32 (1), pp. 93-96Engel Jr., J., Wiebe, S., French, J., Quality Standards Subcommittee of the American Academy of NeurologyAmerican Epilepsy SocietyAmerican Association of Neurological Surgeons. Practice parameter: Temporal lobe and localized neocortical resections for epilepsy: report of the Quality Standards Subcommittee of the American Academy of Neurology (2003) Neurology, 60, pp. 538-547Gilliam, F., Kuzniecky, R., Faught, E., Black, L., Carpenter, G., Schrodt, R., Patient-validated content of epilepsy-specific quality-of-life measurement (1997) Epilepsia, 38 (2), pp. 233-236. , DOI 10.1111/j.1528-1157.1997.tb01102.xLehrner, J., Kalchmayr, R., Serles, W., Olbrich, A., Pataraia, E., Aull, S., Bacher, J., Baumgartner, C., Health-related quality of life (HRQOL), activity of daily living (ADL) and depressive mood disorder in temporal lobe epilepsy patients (1999) Seizure, 8 (2), pp. 88-92. , DOI 10.1053/seiz.1999.0272Perrine, K., Hermann, B.P., Meador, K.J., The relationship of neuropsychological functioning to quality of life in epilepsy (1995) Arch Neurol, 52, pp. 997-1003Boylan, L.S., Flint, L.A., Labovitz, D.L., Jackson, S.C., Starner, K., Devinsky, O., Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy (2004) Neurology, 62 (2), pp. 258-26
